Work

Cover

Year: 2021

Type: article

Abstract: Despite concern that a higher risk of side effects might alter the net risk/benefit ratio for neurohormonal therapy, which includes beta-blockers and ACEi/ARB/ARNI in older HFrEF patients, the benefits of neurohormonal therapy do not decrease with increasing age. See the related article by Gilstrap, pages 2811-2820.

Source: Journal of the American Geriatrics Society

DOI: 10.1111/jgs.17499

Authors: Lauren Gilstrap, Andrea M. Austin, Barbara Gladders, Parag Goyal, A. James O'Malley, Amber Barnato, Anna N. A. Tosteson, Jonathan S. Skinner

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4200047006

FWCI:

Cites:

Cited by:

Related to: 10